News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Samuel Kareff: I’m starting a new position as Medical Oncology/Hematology at Lynn Cancer Institute
Aug 3, 2024, 06:05

Samuel Kareff: I’m starting a new position as Medical Oncology/Hematology at Lynn Cancer Institute

Samuel Kareff, Medical Oncologist and Hematologist at the Lynn Cancer Institute/Center for Hematology-Oncology, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Medical Oncology/Hematology at Lynn Cancer Institute/Center for Hematology-Oncology.”

Source: Samuel Kareff/LinkedIn

cancer Lynn Cancer Institute OncoDaily Oncology Samuel Kareff
Blog
Aug 3, 2024, 06:05
Samuel Kareff: I’m starting a new position as Medical Oncology/Hematology at Lynn Cancer Institute
Insight
Aug 3, 2024, 06:00
Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer
Blog
Aug 3, 2024, 05:29
Renew your ESO College membership for 2025 by registration
Blog
Aug 3, 2024, 04:14
Carolyn Bradner Jasik: A warm welcome to the Omada Health Board of Directors
Blog
Aug 3, 2024, 03:28
Jean-Emmanuel Bibault: ESTRO and American Association of Physicists in Medicine on AI models in radiation therapy
Blog
Aug 3, 2024, 03:01
Belén Garijo on Q2 results from Merck
Blog
Aug 3, 2024, 02:30
Advancing clinical trials at the SCRI Clinical Trials Symposium
Blog
Aug 3, 2024, 02:18
Sean Khozin: Project Data Sphere's bold expedition with Qure.ai to Everest Base Camp and Kala Patthar
Blog
Aug 3, 2024, 02:14
Trish Boh: Experience holistic cancer care at the doTERRA Center for Integrative Oncology
Blog
Aug 3, 2024, 02:11
Eric Vivier: NK1 and NK3 trajectories with the five Olympic Rings
Blog
Aug 3, 2024, 02:04
Rasha Aboelhassan: Maha passed away wondering if there are any screening opportunities for passive smoking
Blog
Aug 3, 2024, 01:46
Saba Ghassemi: Honored to receive my first NIH R01 grant to explore the role of IFN1 signaling in nonactivated CAR T cells